MPJE: Multistate Pharmacy Jurisprudence Examination Quiz: Controlled Recordkeeping
20 questions · exam conditions
0:00
Controlled RecordkeepingQuestion 1 of 20

A pharmacist receives a Schedule II prescription that contains all required elements except the patient's address, which was left blank. Under DEA regulations, which of the following best describes the pharmacist's permissible action?

The pharmacist may not fill the prescription because Schedule II prescriptions must be rejected if any required element is missing.
The pharmacist may add the patient's name and address to the prescription before filling, as this is one of the specific additions expressly permitted by DEA regulation.
The pharmacist must return the prescription to the prescriber to add the missing address before it may be filled.
The pharmacist may fill the prescription as written because the patient's address is not a required Schedule II prescription element.
← Back to quizzes

MPJE: Multistate Pharmacy Jurisprudence Examination Quiz

MPJE: Multistate Pharmacy Jurisprudence Examination Quiz: Controlled Recordkeeping

Practice Controlled Recordkeeping in MPJE: Multistate Pharmacy Jurisprudence Examination with focused quiz questions that help you check what you know, review explanations, and build confidence with test-style prompts.

What this quiz covers

This quiz focuses on Controlled Recordkeeping, giving you a quick way to practice the rules, question types, and explanations that matter most for MPJE: Multistate Pharmacy Jurisprudence Examination.

How to use this quiz

Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.

All questions

Question 1

A pharmacist receives a Schedule II prescription that contains all required elements except the patient's address, which was left blank. Under DEA regulations, which of the following best describes the pharmacist's permissible action?

  1. The pharmacist may not fill the prescription because Schedule II prescriptions must be rejected if any required element is missing.
  2. The pharmacist may add the patient's name and address to the prescription before filling, as this is one of the specific additions expressly permitted by DEA regulation. (correct answer)
  3. The pharmacist must return the prescription to the prescriber to add the missing address before it may be filled.
  4. The pharmacist may fill the prescription as written because the patient's address is not a required Schedule II prescription element.
Explanation: Under 21 CFR 1306.05(a), a pharmacist is expressly permitted to add the patient's name and address to a Schedule II prescription before filling it. This is one of the specific additions DEA regulations authorize pharmacists to make; it does not constitute an impermissible alteration of the prescription. A is incorrect because the regulation specifically provides for pharmacist addition of the patient's name and address; rejecting the prescription outright is not required when this information can be lawfully added. C is incorrect because returning the prescription to the prescriber is not necessary for missing patient address information when the regulation permits the pharmacist to add it. D is incorrect because the patient's name and address are required elements under 21 CFR 1306.05; the prescription is incomplete without them, which is why the regulation provides a specific authorization for the pharmacist to supply them.

Question 2

A hospital pharmacy provides controlled substances to nursing units and documents each transaction in an electronic medication administration record system. Which of the following best describes the hospital pharmacy's DEA controlled substance recordkeeping obligations?

  1. Hospital pharmacies must maintain complete controlled substance records for DEA inspection, retained for at least two years. (correct answer)
  2. Hospital pharmacies are exempt from DEA recordkeeping requirements because they operate under a hospital formulary system.
  3. Only Schedule II records must be maintained; Schedule III through V hospital transactions are exempt.
  4. Hospital pharmacy recordkeeping satisfies DEA requirements if the hospital's Joint Commission accreditation is current.
Explanation: Hospital pharmacies are subject to the same DEA recordkeeping requirements as retail pharmacies. Complete records of all controlled substance transactions must be maintained for at least two years and be available for DEA inspection. B is incorrect because hospital formulary status does not exempt a pharmacy from DEA recordkeeping. C is incorrect because the two-year recordkeeping requirement applies to all schedules; Schedule III-V hospital transactions are not exempt. D is incorrect because Joint Commission accreditation is a quality credential, not a DEA compliance equivalent.

Question 3

A pharmacist partially fills a Schedule II prescription for a patient in a long-term care facility (LTCF). Under DEA recordkeeping requirements, which of the following must be documented for the partial fill?

  1. No special documentation is required because partial fills are treated identically to full fills for recordkeeping purposes.
  2. Partial fills of Schedule II prescriptions are prohibited in all circumstances; documentation of such a fill would itself be a violation.
  3. Document the date, quantity dispensed, quantity remaining, and pharmacist's identity on the prescription for each partial fill. (correct answer)
  4. Documentation of a partial fill requires DEA Form 222 to be executed for each partial dispensing.
Explanation: Schedule II partial fills for LTCF and terminally ill patients are permitted and must be documented on the prescription: date dispensed, quantity dispensed, quantity remaining, and dispensing pharmacist identity. Subsequent partial fills must similarly be documented, and the prescription cannot be filled beyond 60 days from its issue date. A is incorrect because partial fills have specific additional documentation requirements. B is incorrect because Schedule II partial fills are specifically permitted for LTCF patients. D is incorrect because DEA Form 222 is for ordering Schedule I and II substances, not for documenting dispensing.

Question 4

A pharmacy chain uses a centralized server storing controlled substance dispensing records for all five locations. During a DEA inspection of Location 3, the investigator requests records that are only accessible from Location 1's dispensing computer. Which of the following best analyzes whether this system satisfies DEA readily retrievable requirements?

  1. The system satisfies requirements because all records are on the same server and technically accessible from any location.
  2. The system fails requirements if Location 3 cannot independently access its own records without relying on another location. (correct answer)
  3. The system satisfies requirements because chain pharmacies are treated as a single DEA registrant for recordkeeping purposes.
  4. The system satisfies requirements as long as the IT department can retrieve the records within 48 hours.
Explanation: Each DEA registration is location-specific and the registered location must have its records readily retrievable at that address. A centralized system requiring access through another location's system to retrieve one location's records may not satisfy the per-location readily retrievable requirement. A is incorrect because technical accessibility from any location is not the same as having records readily retrievable at the specific registered location. C is incorrect because chain pharmacies have separate DEA registrations with independent recordkeeping obligations. D is incorrect because a 48-hour IT-dependent retrieval may not satisfy the standard, particularly for records that must be immediately available.

Question 5

During a DEA inspection, the investigator requests Schedule II dispensing records from the past 22 months. The pharmacy produces records from the past 18 months but states records from months 19 through 22 ago were destroyed in a water leak with no backup copies. Which of the following best analyzes the compliance concern?

  1. There is no compliance concern because water damage is a force majeure event that excuses recordkeeping failures.
  2. The pharmacy is non-compliant; records must be maintained for two years, regardless of circumstances like water damage. (correct answer)
  3. There is no compliance concern because the pharmacy can produce records for 18 of the 22 months requested.
  4. The pharmacy is compliant as long as the water damage is documented and an insurance claim is filed.
Explanation: DEA records must be maintained for two years. Records from 19 to 22 months ago fall within the retention period and must be available. Destruction by water damage does not discharge the retention obligation, though it may be a mitigating factor in enforcement. The pharmacy must notify the DEA, document the incident, and implement corrective measures. A is incorrect because force majeure does not exempt a registrant from DEA recordkeeping obligations. C is incorrect because partial compliance does not satisfy the full requirement. D is incorrect because an insurance claim does not satisfy the DEA retention obligation.

Question 6

A DEA investigator comparing a pharmacy's Schedule II dispensing records with corresponding prescriptions finds that 15 dispensing log entries have no corresponding prescriptions on file, and 8 prescriptions on file have no corresponding dispensing log entries. Which of the following best analyzes the significance of this finding?

  1. This finding is expected because pharmacies process thousands of transactions and minor discrepancies are normal.
  2. Only the 8 prescriptions with no dispensing log entry are concerning; dispensing log entries without corresponding prescriptions are less significant.
  3. Both discrepancies suggest potential recordkeeping violations or diversion and must be thoroughly investigated to ensure compliance with DEA regulations. (correct answer)
  4. The finding is only significant if the total discrepancy exceeds 10% of all dispensing transactions.
Explanation: Both types of discrepancy raise serious concerns. Dispensing log entries without corresponding prescriptions may indicate controlled substances were dispensed without valid prescriptions -- a significant violation. Prescriptions without dispensing log entries may reflect data entry omissions or could signal misappropriation. Both must be thoroughly investigated. A is incorrect because Schedule II records must be exact and any discrepancy requires investigation. B is incorrect because dispensing log entries without prescriptions are actually the more serious diversion concern, but both categories require investigation. D is incorrect because there is no percentage threshold normalizing controlled substance record discrepancies.

Question 7

A pharmacist discovers that a controlled substance dispensing record from three days ago incorrectly shows 30 tablets dispensed when the patient actually received 60 tablets. How should this error be corrected?

  1. The original entry should be erased and rewritten with the correct quantity to maintain a clean record.
  2. Draw a line through the error, write the correct amount, and initial and date the correction. (correct answer)
  3. The error cannot be corrected; a new prescription must be written to document the correct quantity.
  4. The pharmacist should contact the DEA to request authorization to correct the dispensing record.
Explanation: Controlled substance dispensing records must not be altered in a way that obliterates the original entry. The proper correction method is to draw a single line through the error keeping it legible, write the correct information, and initial and date the correction. A is incorrect because erasing or overwriting the original entry is falsification of a controlled substance record. C is incorrect because a corrected dispensing record annotation is the appropriate mechanism; writing a new prescription is not the correct approach. D is incorrect because DEA authorization is not required to correct a documentation error using the proper annotation method.

Question 8

A state law requires pharmacies to maintain controlled substance dispensing records in a specific format that differs from the DEA format. A pharmacist wants to use the state format to satisfy both requirements simultaneously. Which of the following best analyzes whether the state format can satisfy federal DEA requirements?

  1. The state format automatically satisfies federal requirements because state boards are the primary regulators of pharmacy recordkeeping.
  2. The state format satisfies federal requirements only if individually approved by the DEA.
  3. The state format cannot satisfy federal requirements because state and federal recordkeeping requirements are always completely separate.
  4. The state format satisfies federal requirements if it includes all DEA-required information. (correct answer)
Explanation: A single record can satisfy both state and federal requirements if it captures all information required by each. If the state format is more detailed than federal requirements, it likely satisfies both. If it omits DEA-required elements, the pharmacy must supplement. The more stringent standard governs. A is incorrect because state boards are not the primary regulators of federal DEA recordkeeping requirements. B is incorrect because DEA does not require case-by-case approval of state record formats. C is incorrect as an absolute statement; a well-designed state format may capture all federally required elements.

Question 9

During a DEA audit, an investigator discovers that a pharmacy's Schedule II dispensing records show multiple instances where the quantity dispensed column has been whited out and a different lower quantity written in. The pharmacist explains these were corrections using correction fluid. Which of the following best analyzes the significance of this finding?

  1. This is an acceptable correction method as long as the pharmacist initialed and dated each correction.
  2. This is a minor documentation concern that can be corrected prospectively.
  3. This is acceptable because correction fluid is a standard office tool.
  4. Using correction fluid on controlled substance records is prohibited and may lead to legal consequences. (correct answer)
Explanation: Obliterating original entries in controlled substance records through correction fluid is a serious DEA violation. Original entries must remain legible and any correction must be made by single-line strikethrough with annotation. Hiding original entries may constitute falsification of federal records, which can carry criminal penalties. A is incorrect because initialing a whited-out correction does not remediate the underlying obliteration of the original entry. B is incorrect because this is not a minor concern; obliteration of controlled substance records is a substantive violation. C is incorrect because the general utility of correction fluid does not make it acceptable for altering federal controlled substance records.

Question 10

A PIC grants a power of attorney (POA) to a staff pharmacist authorizing that pharmacist to sign DEA Form 222 for ordering Schedule II controlled substances. What are the recordkeeping obligations related to this POA?

  1. A DEA POA need not be documented in writing as long as the PIC verbally notifies the DEA regional office.
  2. The POA must be written, signed by the registrant and attorney-in-fact, and kept on file at the pharmacy. (correct answer)
  3. A DEA POA is registered with the DEA central database; no separate pharmacy-level documentation is required.
  4. The POA may be granted orally and maintained in the pharmacy's verbal authorization log.
Explanation: A DEA power of attorney for signing DEA Form 222 must meet the execution requirements of 21 CFR 1305.05: it must be in writing and signed by the registrant or a partner or officer of the registrant, the attorney-in-fact, and two witnesses. The executed POA must be maintained at the pharmacy as part of the controlled substance records. When the authorization is revoked, the revocation must also be documented and retained with the POA. A is incorrect because oral notification to the DEA is not the required mechanism; written execution and on-site retention are required. C is incorrect because DEA POAs are not registered in a DEA central database; they are maintained at the pharmacy. D is incorrect because oral grants do not satisfy DEA requirements; written execution with the required signatures is mandatory.

Question 11

A DEA investigator requests all controlled substance receiving records for the past 18 months. The pharmacy states the records are available but will take 24 to 48 hours to retrieve from its paper archive. Which of the following best describes whether this satisfies the readily retrievable standard?

  1. It depends on the record type; some must be immediate, others within two business days, potentially satisfying the standard. (correct answer)
  2. The 24-to-48-hour timeline automatically satisfies the readily retrievable standard for all types of controlled substance records.
  3. The 24-to-48-hour timeline is non-compliant for all types of records; all controlled substance records must be immediately available during DEA inspections.
  4. The timeline satisfies the standard as long as the pharmacist provides a written explanation to the DEA.
Explanation: The readily retrievable standard varies by record type. Executed order forms, inventories, and current DEA registrations must be immediately available. Other records must be produced within two business days. Whether 24-48 hours satisfies the standard depends on the specific record type and whether the timeline falls within two business days. B is incorrect because not all records have a two-business-day window; some must be immediately available. C is incorrect because immediate availability is not required for all records. D is incorrect because a written explanation does not extend the compliance timeframe.

Question 12

A pharmacy uses the Controlled Substance Ordering System (CSOS) for electronic ordering of Schedule II controlled substances instead of paper DEA Form 222. What are the recordkeeping requirements for CSOS orders?

  1. CSOS orders do not require recordkeeping because electronic transmissions are automatically archived by the DEA.
  2. CSOS order records must be printed and filed in paper form; electronic records alone are not sufficient.
  3. CSOS records must be maintained electronically for two years and be readily retrievable for DEA inspection. (correct answer)
  4. CSOS orders are archived by the distributor; the pharmacy need only maintain confirmation receipts from the distributor.
Explanation: CSOS is the DEA-authorized electronic equivalent of DEA Form 222. Electronic CSOS records must be maintained at the registered location for at least two years, and must be retrievable and printable for DEA inspection, serving the same function as Copy 3 of the paper form. A is incorrect because DEA does not archive CSOS records on the pharmacy's behalf. B is incorrect because properly maintained electronic CSOS records satisfy the requirement without printed paper equivalents. D is incorrect because the pharmacy bears the record-retention obligation; distributor archives do not satisfy the pharmacy's duty.

Question 13

A pharmacist transfers a paper Schedule III controlled substance prescription from one pharmacy to another for refill purposes. What recordkeeping obligations apply to both the transferring and receiving pharmacies?

  1. No recordkeeping is required by either pharmacy for prescription transfers; the prescription itself moves with the patient.
  2. Only the receiving pharmacy must document the transfer; the transferring pharmacy has no ongoing recordkeeping obligation.
  3. Both pharmacies must document the transfer details, including dates and pharmacist identities, and adhere to refill limits. (correct answer)
  4. Schedule III prescription transfers require DEA pre-approval; both pharmacies must submit Form 222.
Explanation: When a paper Schedule III prescription is transferred for refill purposes, the transferring pharmacy must annotate the original prescription with the transfer date, the transferring pharmacist's identity, and the receiving pharmacy's information. The receiving pharmacy must document the receipt and may not dispense beyond the original authorized number of refills. Note that electronic controlled substance prescriptions are subject to different transfer requirements under 21 CFR Part 1311, which permits a one-time transfer of an electronic prescription for initial filling. A is incorrect because both pharmacies have documentation obligations for the transfer. B is incorrect because the transferring pharmacy must annotate the original prescription as described. D is incorrect because DEA Form 222 applies to Schedule I and II ordering, not Schedule III prescription transfers; DEA pre-approval is not required.

Question 14

A pharmacy uses an electronic dispensing system to record all controlled substance transactions. What requirements must the electronic system meet to satisfy DEA controlled substance recordkeeping obligations?

  1. Electronic records are not acceptable for controlled substance recordkeeping; DEA requires paper records for all controlled substance transactions.
  2. Electronic records are acceptable for Schedules III through V but not for Schedule II; Schedule II records must be on paper.
  3. Electronic records must ensure integrity, prevent alterations, provide an audit trail, and allow retrieval and printing for DEA inspection. (correct answer)
  4. Electronic records satisfy DEA requirements as long as the system was purchased from a DEA-approved vendor.
Explanation: DEA regulations permit electronic recordkeeping for controlled substances if the system maintains record integrity, prevents unauthorized alterations, provides an audit trail for any changes, and allows records to be separated and produced for inspection within the readily retrievable standard. A is incorrect because DEA regulations explicitly permit qualifying electronic records. B is incorrect because electronic records are acceptable for all schedules; the distinction between CII and CIII-V does not affect acceptability of electronic systems. D is incorrect because DEA does not maintain a list of approved vendors; the system must meet the regulatory standards.

Question 15

Under 21 CFR 1304.04, what is the minimum retention period for all controlled substance records maintained by a DEA-registered pharmacy?

  1. Two years from the date the transaction occurred or the record was created. (correct answer)
  2. Five years, because controlled substance records require extended retention given their regulatory importance.
  3. One year for Schedules III through V and two years for Schedule II.
  4. Records must be kept until the next DEA inspection and may be destroyed afterward.
Explanation: 21 CFR 1304.04 requires all controlled substance records to be maintained for at least two years, applicable to all schedules including prescriptions, order records, receiving records, and inventories. B is incorrect because the federal minimum is two years, not five. C is incorrect because the two-year standard applies to all schedules equally; there is no one-year tier for Schedules III through V. D is incorrect because records must be retained for the full two-year period regardless of DEA inspection timing.

Question 16

A pharmacy uses DEA Form 222 to order Schedule II controlled substances. How must Copy 3 of each executed Form 222 be maintained?

  1. Copy 3 must be maintained at the registered location and retained for at least two years; DEA executed order forms must be kept separately from other records and be readily retrievable. (correct answer)
  2. Copy 3 may be discarded once the order has been received and verified, because the receiving record serves as permanent documentation.
  3. Copy 3 must be mailed to the DEA regional office within 30 days of order completion.
  4. Copy 3 must be retained for only 90 days because it is a transactional record rather than a dispensing record.
Explanation: The pharmacy must retain Copy 3 of each executed DEA Form 222 at the registered location for at least two years, separately from other records and readily retrievable. Copy 3 documents both the order placed and receipt confirmation. B is incorrect because Copy 3 is not discarded after receipt; it is the pharmacy's permanent order record. C is incorrect because Copy 3 is retained by the pharmacy, not sent to the DEA. D is incorrect because the two-year retention requirement applies to order forms just as it applies to other controlled substance records.

Question 17

When a pharmacy receives a shipment of Schedule II controlled substances, which information must be documented in the receiving record?

  1. Only the drug name and quantity received; other details are maintained in the supplier's records.
  2. The date of receipt, the name and address of the supplier, and the total cost of the shipment.
  3. The date of receipt, the drug name and quantity, and the name of the staff member who accepted the delivery.
  4. The date of receipt, drug details, supplier's DEA number, and pharmacy's DEA number recorded on DEA Form 222 Copy 3. (correct answer)
Explanation: When Schedule II controlled substances are received, the pharmacy must complete the receiving portion of DEA Form 222 Copy 3 with the required information: date of receipt, supplier name and address, supplier DEA number, drug name, dosage form, strength, and quantity received. A is incorrect because drug name and quantity alone are insufficient; supplier identity and DEA number are also required. B is incorrect because cost of shipment is not a required DEA element. C is incorrect because the staff member's name is not the primary regulatory element required.

Question 18

Under federal DEA regulations, what recordkeeping is required when a pharmacy sells Schedule V controlled substances without a prescription where permitted by state law?

  1. No records are required for Schedule V OTC sales; Schedule V is the lowest schedule and has no recording requirements.
  2. The pharmacist must file a DEA Form 222 for each Schedule V OTC sale.
  3. The pharmacist must enter each sale in the state PDMP system before dispensing.
  4. Record each sale in a bound book with purchaser details, sale date, drug name and quantity, and pharmacist's signature or initials. (correct answer)
Explanation: Under 21 CFR 1306.26, Schedule V controlled substances dispensed without a prescription must be documented in a bound record book with: purchaser name and address, date of sale, name and quantity of the Schedule V product, and the dispensing pharmacist's signature or initials. Quantity limits also apply. A is incorrect because Schedule V OTC sales do have federal recordkeeping requirements. B is incorrect because DEA Form 222 is for ordering Schedule I and II substances, not for documenting OTC sales. C is incorrect because PDMP entry is a state-law requirement separate from the federal Schedule V OTC sales log.

Question 19

A pharmacy is permanently closing and surrendering its DEA registration. What must happen to the controlled substance records?

  1. Records must be kept for two years after creation, accessible to the DEA. (correct answer)
  2. All controlled substance records may be destroyed when the pharmacy closes and the DEA registration is surrendered.
  3. All controlled substance records must be transferred to the DEA regional office upon closure.
  4. Records must be transferred to the nearest pharmacy within 5 miles.
Explanation: When a pharmacy closes, DEA records must still be retained for the full two-year period from each record's creation date. The closing pharmacy must arrange for continued record accessibility -- whether by retaining them personally or through a successor entity. B is incorrect because closing the pharmacy does not authorize immediate record destruction; the two-year retention obligation continues. C is incorrect because DEA records are not transferred to the DEA regional office upon closure. D is incorrect because transferring records to a nearby pharmacy is not the correct mechanism.

Question 20

A pharmacy uses DEA filing Option 3, maintaining all prescriptions in a single chronological file. What must be done to each Schedule III and IV prescription filed in this combined system?

  1. The prescription must be stamped with the DEA schedule number such as CIV.
  2. The prescription must be placed in a different colored folder to distinguish it from non-controlled prescriptions.
  3. Each Schedule III and IV prescription must be marked with a red C at least 1 inch in height on its face before filing, making it readily identifiable within the combined file. (correct answer)
  4. No special marking is required as long as the pharmacy maintains an electronic cross-reference showing which prescriptions are Schedule III or IV.
Explanation: Under DEA filing Option 3, Schedule III through V prescriptions filed in a combined file must be marked with a red C no less than 1 inch in height on the face of the prescription. This allows controlled substance prescriptions to be readily identified and separated for DEA inspection. A is incorrect because stamping the schedule number is not the DEA standard; the red C is specified. B is incorrect because colored folders are not the DEA marking standard. D is incorrect because an electronic cross-reference does not satisfy the physical red C marking requirement for paper prescriptions under Option 3.